Order Article Reprints

Chikileva IO, Bruter AV, Persiyantseva NA, Zamkova MA, Vlasenko RY, Dolzhikova YI, Shubina IZ, Donenko FV, Lebedinskaya OV, Sokolova DV, et al. Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment. Biomedicines. 2023; 11(9):2563. https://doi.org/10.3390/biomedicines11092563

Chikileva, Irina O., Alexandra V. Bruter, Nadezhda A. Persiyantseva, Maria A. Zamkova, Raimonda Ya. Vlasenko, Yuliya I. Dolzhikova, Irina Zh. Shubina, Fedor V. Donenko, Olga V. Lebedinskaya, Darina V. Sokolova, and et al. 2023. "Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment" Biomedicines 11, no. 9: 2563. https://doi.org/10.3390/biomedicines11092563

Chikileva, I. O., Bruter, A. V., Persiyantseva, N. A., Zamkova, M. A., Vlasenko, R. Y., Dolzhikova, Y. I., Shubina, I. Z., Donenko, F. V., Lebedinskaya, O. V., Sokolova, D. V., Pokrovsky, V. S., Fedorova, P. O., Ustyuzhanina, N. E., Anisimova, N. Y., Nifantiev, N. E., & Kiselevskiy, M. V. (2023). Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment. Biomedicines, 11(9), 2563. https://doi.org/10.3390/biomedicines11092563